Assessing Amrize: Insights From 8 Financial Analysts
8 analysts have shared their evaluations of Amrize (NYSE:AMRZ) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 3 | 0 | 0 |
| Last 30D | 0 | 2 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Analysts have set 12-month price targets for Amrize, revealing an average target of $63.0, a high estimate of $70.00, and a low estimate of $57.00. Witnessing a positive shift, the current average has risen by 6.1% from the previous average price target of $59.38.
Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive Amrize. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Bryan Blair | Oppenheimer | Raises | Outperform | $70.00 | $64.00 |
| Anthony Codling | RBC Capital | Raises | Sector Perform | $61.00 | $60.00 |
| Timna Tanners | Wells Fargo | Raises | Overweight | $66.00 | $59.00 |
| Timna Tanners | Wells Fargo | Raises | Overweight | $59.00 | $58.00 |
| Bryan Blair | Oppenheimer | Raises | Outperform | $64.00 | $62.00 |
| Anthony Pettinari | Citigroup | Raises | Buy | $67.00 | $63.00 |
| Marcus Cole | UBS | Raises | Neutral | $57.00 | $53.00 |
| Anthony Codling | RBC Capital | Raises | Sector Perform | $60.00 | $56.00 |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Amrize. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Amrize compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Amrize's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Amrize analyst ratings.
Delving into Amrize's Background
Amrize is a building solutions company focused exclusively on the North American market. Amrize earns revenue from the sale of cement, aggregates, ready-mix concrete, asphalt, roofing systems, and other building solutions. The company is organized into two reportable segments: building materials and building envelope. The building materials business consists of Amrize's cement, aggregates, ready-mix concrete, and asphalt operations. The building envelope segment offers advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings, along with adhesives, tapes, and sealants.
Unraveling the Financial Story of Amrize
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Amrize's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 6.65%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: Amrize's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.83% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Amrize's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.3%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Amrize's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.28%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.53.
What Are Analyst Ratings?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.